Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ADVB
Advanced Biomed Inc.
CAPPED RATING
Advanced Biomed Inc. (ADVB) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Momentum (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.1
/ 5.0
C-
Value
C+
Factor Score
2.8
/ 5.0
Growth
C+
Factor Score
2.5
/ 5.0
Profitability
D
Factor Score
1.5
/ 5.0
Momentum
D
Factor Score
1.3
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
N/A
EV / EBITDA
-1.0
Rev Growth YoY
N/A
Gross Margin
N/M
Price Return 3M
-74.5%
Price Return 12M
-75.2%
Catalyst Signal
0.00
Market Cap
$3.7M
TTM Revenue
$127.6K
Price / Sales
28.7
ROE
-79.5%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C+ (2.8) | C+ (2.5) | D (1.5) | D (1.3) | C+ (2.6) | C- (2.1) |
| 2026-11-10 | C+ (2.8) | C+ (2.5) | D (1.5) | D+ (1.7) | C+ (2.6) | C (2.2) |
| 2026-11-03 | B- (2.9) | C+ (2.5) | D (1.4) | D+ (1.7) | C+ (2.7) | C (2.2) |
| 2026-10-27 | C+ (2.8) | C+ (2.5) | D (1.4) | D+ (1.8) | C+ (2.6) | C (2.2) |
| 2026-10-20 | C+ (2.7) | C+ (2.5) | D (1.4) | C (2.3) | C+ (2.6) | C (2.3) |
Page
1
of
4